Displaying drugs 14176 - 14200 of 14648 in total
AZD3409
AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been discontinued.
Investigational
Matched Description: … Phase I trials were initiated January 2003, and were ongoing as of February 2004. …
Embutramide
Experimental
Illicit
SC-74020
Experimental
R048-8071
Experimental
N-Cyclohexyl-N'-(4-Iodophenyl)Urea
Experimental
N-Butyl-Benzenesulfonamide
Experimental
3,5-Difluorobenzenesulfonamide
Experimental
4-iodo-acetamido phenylboronic acid
Experimental
PASBN
Experimental
N-[Tosyl-D-Prolinyl]Amino-Ethanethiol
Experimental
4-Phenylbutylamine
Experimental
2,3-Difluorobenzyl Alcohol
Experimental
Phenethylamine
Experimental
Soneclosan
Experimental
Displaying drugs 14176 - 14200 of 14648 in total